All fields · Computational Theory and Mathematics

JournalQ1· SCImago 2025

Journal of Medicinal Chemistry

ISSN 0022-2623

• Q1Quartile
• 1.00SJR
• 329h-index
• 21papers summarised

About this journal

Journal of Medicinal Chemistry is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 1.00 and an h-index of 329. Most of its papers in the Pofolia pool fall under Computational Theory and Mathematics. Pofolia holds AI summaries of 21 paper(s) from this journal; the most cited is “Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen…” (6286 citations).

The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal? · What is the h-index?

Most-cited papers in Computational Theory and Mathematics →

Papers we summarise from this journal

• Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals2014 · 6286 citations
• pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures2015 · 5474 citations
• Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design2018 · 2565 citations
• Rings in Drugs2014 · 2474 citations
• Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking2012 · 2430 citations
• QSAR Modeling: Where Have You Been? Where Are You Going To?2013 · 2097 citations
• Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands2012 · 1329 citations
• Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology2012 · 1311 citations
• A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design2015 · 771 citations
• Exploring a Druggable Hydrophobic Tunnel in the 5-HT2A Receptor with Potent Phenethylamines2026 · 4 citations
• How Many Crystal Structures Do You Need to Trust Your Docking Results?2026 · 1 citations
• Discovery of DT-9081, a Potent and Orally Bioavailable Small Molecule Antagonist of the EP4 Receptor for the Treatment of Solid Cancers2026 · 1 citations
• Imidazo[1,2- a ]pyrazine Derivatives as Dual A2A/A2B Adenosine Receptor Antagonists Enhancing Anti-PD-1 Antibody Therapy in Colorectal Cancer2026 · 0 citations
• Dual Peptide Modification via Isopeptide Bonding and Lipidation Boosts Antifungal Activity2026 · 0 citations
• Structure-Guided Discovery of Orally Bioavailable Allosteric SLC6A19 Inhibitors that Promote Urinary Amino Acid Excretion In Vivo2026 · 0 citations
• Simplification and Derivatization of Quinoline-Containing M41 Lead to the Discovery of NADPH Oxidase Isoform-Selective Inhibitors Effective in Cancer Cells2026 · 0 citations
• Design, Synthesis, and Biological Evaluation of Novel Tetrazole-Containing Tetrahydroisoquinoline Derivatives as Putative CYP51 Inhibitors against Candida Species2026 · 0 citations
• Discovery of LB10, a Potent and Orally Bioavailable Inhibitor of Ecto-5′-Nucleotidase as a Single Agent or in Combination for the Treatment of Lung Cancer2026 · 0 citations
• Albumin-Binding Modification Improves Tumor Retention of Hydrophilic αvβ6-Targeting Radiotheranostic Tracers2026 · 0 citations
• Structure-Based Optimization of 2-Aminopyrimidine Derivatives as Potent Multi-target FLT3/CHK1/IRAK4 Inhibitors for Acute Myeloid Leukemia2026 · 0 citations
• Discovery of Long-Acting Bifunctional Compounds with Muscarinic M3 and Histamine H1 Receptor Antagonism for the Treatment of Rhinitis2026 · 0 citations

Journals in the same field

See every journal in the field →